The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments. IBM: International Business Machines . . . or “Incredible ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing’s promise in medicine. While Moderna isn’t looking to replace ...

Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies.

Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies.

The IBM-VMware partnership and the transition and impact of Broadcom's acquisition of VMware were discussed by Brendan Kinkade of IBM.

Shares of International Business Machines fell nearly 7% in morning trading on Thursday after the company said some of its federal contracts were suspended, while an uncertain economy poses a ...

GSK's lawsuit adds uncertainty to Moderna's already declining stock, increasing short-selling activity. Read why I downgrade MRNA from buy to hold.

IBM refers to the model as one that can “learn the grammar of molecules.” “We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of ...

"We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of quantum computing, and ready our business for these game-changing technologies.

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM announced an agreement under which Moderna will explore next generation technologies including ...

“ IBM ’s purpose is to be the catalyst to make the world work better, perfectly exemplified by this partnership with Moderna. We are witnessing a revolution in the world of computing, driven by ...

Under this initiative, Moderna and IBM will combine state-of-the-art formulation discovery with generative AI to design mRNA medicines with optimal safety and performance.